Cerus affirms positive results for Phase 3 transfusion study assessing INTERCEPT RBC’s in Thalassemia patients Read more
Tabuk Pharmaceuticals enters into licensing and supply agreement with red otc development GmbH Read more
FDA offers supplementary clearances to Bio-Rad’s IH-System Gel Reagents, Blood Typing Products Read more
Astellas Pharma and Vical asserts negative Phase 3 Clinical Trial results for ASP0113 for CMV-HSCT recipients Read more